JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VAN WOERT, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VAN WOERT, M. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 173, Issue 2, 256-264, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF PHENOTHIAZINES ON MELANOMA TYROSINASE ACTIVITY

MELVIN H. VAN WOERT 1

1 Departments of Internal Medicine and Pharmacology, Yale University School of Medicine, New Haven, Connecticut

Chronic chlorpromazine (CPZ) administration was demonstrated to increase the tyrosinase activity in the B-16 melanoma in vivo. In vitro, 10-3 M CPZ produced a 2-fold increase in the B-16 melanoma tyrosinase and a 50% increase in Harding-Passey melanoma tyrosinase. Other phenothiasine compounds also activated melanoma tyrosinase. Substituents in position 2 in the phenothiasine ring showed the following order of potency for activating tyrosinase: CF3 > Cl > H. At position 10 of phenothiasine a piperazinoalkyl side chain was more effective in increasing tyrosinase activity than an aliphatic amine. The activation of melanoma tyrosinase by CPZ was greatest in the melanosomal fraction of the melanocyte. Digitonin or a non-ionic detergent, Igepal CO-630, eliminated the increase in melanoma tyrosinase induced by CPZ. CPZ appears to increase melanoma tyrosinase activity by an indirect mechanism, probably related to changes in melanosomal membrane permeability. CPZ did not activate mushroom tyrosinase, serum tyrosinase from melanoma-bearing mice or rat adrenal tyrosine hydroxylase; inhibition of these soluble enzymes occurred in the presence of high concentrations of CPZ. CPZ also increased the incorporation of C14-dopa into the B-16 melanoma in vivo.

Submitted on July 28, 1969
Accepted on February 25, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.